Population Pharmacokinetics and Exposure-Response with Durvalumab Plus Platinum-Etoposide in ES-SCLC: Results from CASPIAN
dc.contributor.author | Jin, D. | |
dc.contributor.author | Roskos, L. | |
dc.contributor.author | Guan, Y. | |
dc.contributor.author | Zheng, Y. | |
dc.contributor.author | Liu, Y. H. | |
dc.contributor.author | Chen, C. | |
dc.contributor.author | Armstrong, J. | |
dc.contributor.author | Jiang, H. | |
dc.contributor.author | Paz-Ares, L. | |
dc.contributor.author | Hochmair, M. | |
dc.contributor.author | Havel, L. | |
dc.contributor.author | Chen, Y. | |
dc.contributor.author | Poltoratskiy, A. | |
dc.contributor.author | Trukhin, D. | |
dc.contributor.author | Ozguroglu, M. | |
dc.date.accessioned | 2021-12-10T12:48:26Z | |
dc.date.available | 2021-12-10T12:48:26Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Zheng Y., Jin D., Guan Y., Ozguroglu M., Trukhin D., Poltoratskiy A., Chen Y., Havel L., Hochmair M., Paz-Ares L., et al., "Population Pharmacokinetics and Exposure-Response with Durvalumab Plus Platinum-Etoposide in ES-SCLC: Results from CASPIAN", JOURNAL OF THORACIC ONCOLOGY, cilt.16, sa.3, 2021 | |
dc.identifier.issn | 1556-0864 | |
dc.identifier.other | av_d850589e-f48e-4553-87ac-8a979acacdaf | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/174708 | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp | |
dc.subject | Health Sciences | |
dc.subject | Pulmonary and Respiratory Medicine | |
dc.subject | Respiratory Care | |
dc.subject | Oncology | |
dc.subject | Onkoloji | |
dc.subject | İç Hastalıkları | |
dc.subject | Göğüs Hastalıkları ve Allerji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | SOLUNUM SİSTEMİ | |
dc.title | Population Pharmacokinetics and Exposure-Response with Durvalumab Plus Platinum-Etoposide in ES-SCLC: Results from CASPIAN | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF THORACIC ONCOLOGY | |
dc.contributor.department | Astrazeneca , , | |
dc.identifier.volume | 16 | |
dc.identifier.issue | 3 | |
dc.contributor.firstauthorID | 2621997 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Makale [92796]